H&E stain

Global Slide Stainers Market (2022 to 2027) - Increasing Number of Clinical Trials Pertaining to Cancer Drugs Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 12, 2022
Oncology, Health, Chemicals, Plastics, Manufacturing, Clinical Trials, Research, Science, Stomach, Microbiology, Prevalence, Diagnosis, Lymphoma, Infection, CAGR, Biotechnology, Hospital, Patient, H&E stain, Research, Technology, Cancer, Breast cancer, Conditional sentence, Ziehl–Neelsen stain, Immunohistochemistry, Hematology, COVID-19, USD, Medical imaging

The slide stainer market by product is further segmented into the slide stainer market is segmented into reagents & kits, equipment, and consumables & accessories.

Key Points: 
  • The slide stainer market by product is further segmented into the slide stainer market is segmented into reagents & kits, equipment, and consumables & accessories.
  • The slide stainer market by technology is further segmented into the slide stainer market is segmented into hematoxylin & eosin, immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special staining.
  • The increasing cases of cancer, such as breast cancer, gastric cancer, lymphoma, etc., and infections.
  • In 2021, the slide stainer market was further divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Fluidigm Announces Co-Marketing Agreement with Ultivue for Biomarker Imaging Solutions for Precision Medicine

Retrieved on: 
Thursday, August 5, 2021
H&E stain, Efficiency, Research, Chief executive officer, U.S. Securities and Exchange Commission, Solution, Forward-looking statement, United, Industry, Life, Corporate development, Technology, Coronavirus, Data analysis, Annual report, Government, Private Securities Litigation Reform Act, Regulation, Security (finance), Mass cytometry, TIS, Health, Twitter, Microfluidics, Biomarker, GLOBE, Quality of life, Mass, Cancer, Regulation Fair Disclosure, SAN, Triage, Precision medicine, Social media, Immunotherapy, CyTOF, Drug development, Biotechnology, Disclosure, LinkedIn, Acquisition, Nasdaq, Disease, Pharmaceutical industry, Medical imaging, Risk management

Ultivue , a leader in advancing precision medicine solutions by accelerating tissue biomarker discovery and validation, develops unique assays for use in multiplex immunofluorescence imaging and analysis.

Key Points: 
  • Ultivue , a leader in advancing precision medicine solutions by accelerating tissue biomarker discovery and validation, develops unique assays for use in multiplex immunofluorescence imaging and analysis.
  • For example, InSituPlex technology is well-suited to identify regions of interest that may require downstream, deep profiling with Imaging Mass Cytometry.
  • Ultivue is at the forefront of innovation to provide unique biological insights for our customers, said Mark Rees, Vice President of Corporate Development for Ultivue.
  • Through Fluidigm Therapeutic Insights Services, we will offer our customers access to our technology as well as that of Ultivue, providing optimum imaging solutions for biomarker discovery and drug development.

Slide Stainer Market Worth 4.70 billion USD by 2023

Retrieved on: 
Monday, July 2, 2018
Microscopy, Staining dyes, Histology, Anatomy, Staining, Laboratory techniques, Histotechnology, H&E stain, Eosin, Haematoxylin, Immunohistochemistry, Agilent Technologies

According to a new market research report "Slide Stainer Market by Product (Reagent, Equipment (Automated, Manual)), Technology (Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, Special Stains), End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2023", published by MarketsandMarkets, the market is expected to reach USD 4.70 billion by 2023 from an estimated USD 2.79 billion in 2018, at a CAGR of 11.0%.

Key Points: 
  • According to a new market research report "Slide Stainer Market by Product (Reagent, Equipment (Automated, Manual)), Technology (Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, Special Stains), End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2023", published by MarketsandMarkets, the market is expected to reach USD 4.70 billion by 2023 from an estimated USD 2.79 billion in 2018, at a CAGR of 11.0%.
  • On the basis of product, the reagents segment accounted for the largest share of the global Slide Stainers Market in 2017.
  • Based on technology, the Slide Stainers Market is segmented into hematoxylin and eosin (H&E), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains.
  • North America accounted for the largest share of the Slide Stainers Market in 2017, followed by Europe and Asia Pacific.